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Conclusion: Regarding the CTO intervention outcomes following PCI with DESs,
there was no significant difference between diabetics and non-diabetics in procedure
related complications and one year cumulative clinical outcomes.
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Background: Chronic dialysis patients (pts) are at an increased risk of peripheral artery
disease. Outcome of below the knee (BTK) intervention in dialysis patients remains
poorly understood. The aim of this study is to clarify the BTK intervention outcomes
in dialysis pts as compared with those without on dialysis.
Methods: A total 82 consecutive patients who underwent BTK intervention were
enrolled for the study. Study population was divided into 2 groups; Control group-no
dialysis (n= 68 pts, 105 lesions) and Dialysis group-peritoneal or hemodialysis (n=14
pts, 34 lesions). Procedural and major clinical outcomes up to 1 year were compared
between the two groups.
Results: Baseline clinical, procedural and angiographic characteristics were similar
between the two groups. Post procedural ischemic complications and major clinical
outcomes including mortality and repeat PTA were similar between the two groups up
to 1 year. However, the incidence of surgical intervention for wound management
including ostectomy & amputation were significant higher in the dialysis group. (Table)
Conclusion: In this study, despite of similar major angiographic and clinical outcomes
following successful BTK intervention in dialysis pts, they had significant higher rate
of surgical intervention including ostectomy and amputation up to one year, suggesting
special care with intensive medical management should be recommend.
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Background: Diabetes mellitus is a major risk factor for coronary artery disease
(CAD) and prone to a diffuse, multivessel and rapidly progressive form. Optimal
revascularization treatment in diabetic and nondiabetic patients with multivessel CAD
remains in dispute.
Methods: We evaluated 3,042 patients with multivessel disease who received DES
(n=1,547) or underwent CABG (n=1,495) between January 2003 and December 2005
and for whom complete follow-up data were available for median 5.6 years. We
compared the effects of DES and CABG on adverse outcomes (death; a composite
outcome of death, myocardial infarction [MI], or stroke; and repeat revascularization),
according to diabetic status.
Results: In diabetic patients, after adjustment for differences in baseline risk factors,
5-year risk of death (hazard ratio [HR]: 1.12; 95% confidence interval [CI], 0.72 to
2.09; P=0.61) and composite of death, MI, or stroke (HR: 1.23; 95% CI, 0.81 to 1.85;
P=0.34) were similar between the DES and CABG group. However, the rate of repeat
revascularization was significantly higher in the DES group than in the CABG group
(HR: 3.28; 95% CI, 1.94 to 5.54; P<0.001). These trends were consistent in nondiabetic
patients (HR: 0.86; 95% CI, 0.61 to 1.12; P=0.40 for death, HR: 0.81; 95% CI, 0.61 to
1.09; P=0.17 for composite of death, MI, or stroke, HR: 2.80; 95% CI, 2.00 to 3.92;
P<0.001 for repeat revascularization). In addition, we did not observe significant
interaction between treatment outcomes and diabetic status (Pinteraction = 0.22 for
death, Pinteraction = 0.13 for composite of death, MI, or stroke, Pinteraction = 0.46
for repeat revascularization).
Conclusion: For multivessel CAD patients receiving percutaneous or surgical
revascularization, there was no significant difference of treatment effect according to
diabetic status.
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Background: We performed a patient level meta-analysis of 9-month clinical outcome
in diabetic versus non-diabetic patients with coronary bifurcation lesions treated by
drug eluting stents based on the British Bifurcation Coronary Old New and Evolving
strategies study (BBC ONE), the Nordic Bifurcation Study, the Nordic Bifurcation
Stent Technique Study and the Nordic-Baltic Bifurcation study III on final kissing
balloon dilatation.
Methods: Nine-month clinical follow-up were available for a total of 1816 patients
including 249 diabetic patients. MACE results were analyzed by propensity score
adjusted Cox regression.
Results: The mean age was 65±9 years in the diabetes group and 63±10 years in non-
diabetes group. In the diabetes and non-diabetes groups, 24% and 28% were females,
mean main vessel reference diameters were 3.3 mm vs. 3.2 mm, and side branch
reference diameters were 2.6 mm vs. 2.5 mm, respectively. True bifurcation lesions
were treated in 63 % vs. 66 % and complex stenting techniques were performed in
45% in 49% of cases in diabetic and non-diabetic patients. Major Adverse Cardiac
Events (MACE) rate was 8.8% in diabetic patients vs. 7.5% in non-diabetic patients
(HR 1.2 [95% CI 0.7 to 1.8], p= 0.48). MACE was a composite endpoint of total death
(1.6 vs 1.0%, p=0.42), non procedure-related myocardial infarction (1.6% vs. 2.2%,
p=0.59) and target vessel revascularization (7.6% vs. 6.2%, p=0.38). Procedure-related
myocardial infarction occurred in 9.6% of diabetic patients vs. 6.3% in non-diabetic
patients (p=0.049).
Conclusion: Diabetes was not associated with increased 9-month MACE in patients
treated for bifurcation lesions with drug eluting stents in BBC ONE and the Nordic
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